amoxicillin has been researched along with Disease Models, Animal in 93 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (11.83) | 18.7374 |
1990's | 28 (30.11) | 18.2507 |
2000's | 26 (27.96) | 29.6817 |
2010's | 21 (22.58) | 24.3611 |
2020's | 7 (7.53) | 2.80 |
Authors | Studies |
---|---|
Matsuda, K; Matsumoto, S; Matsumoto, Y; Sasaki, H; Takasugi, H; Yoshida, Y | 1 |
Abgueguen, P; Azoulay-Dupuis, E; Bedos, JP; Fantin, B; Moine, P; Noel, V; Rieux, V | 1 |
Giamarellou, H; Kyroudi, A; Papalois, A; Pefanis, A; Skiadas, I; Triantafyllidi, H; Tsaganos, T | 1 |
Dussurget, O; Fontanet, A; Grayo, S; Join-Lambert, O; Le Monnier, A; Lott-Desroches, MC; Respaud, R; Singlas, E | 1 |
Avdeef, A; Tam, KY | 1 |
Iwashita, N; Matayoshi, S; Nakano, K; Nomura, R; Otsugu, M; Suehiro, Y | 1 |
Hassan, WA; Mansour, HA; Shawky, E; Soliman, MG | 2 |
Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z | 1 |
Chakraborty, S; Cheng, X; Chiu, N; Galla, S; Joe, B; Mell, B; Vijay-Kumar, M; Wenceslau, CF; Yeo, JY | 1 |
Amirsadeghi, A; Azarpira, N; Hassanajili, S; Jafari, A | 1 |
Butts, CA; Carpenter, EA; Dinnan, H; Hedderley, DI; Martell, S; Paturi, G; Stoklosinski, H | 1 |
Faller, WJ; Garcia, TM; Koelink, PJ; Koster, J; Meisner, S; Muncan, V; Renes, IB; Silva, J; Smit, WL; van Elburg, RM; van Roest, M; Vermeulen, JLM; Wildenberg, ME | 1 |
Feliciano, CP; Ikeda, Y; Nagasaki, Y; Saito, S; Shoji, K | 1 |
Bafor, EE; Eferoba-Idio, E; Eghianruwa, OJ; Itemire, AO; Odega, K; Omoruyi, O; Onwukpa, I | 1 |
Croitoru, K; Goethel, A; Philpott, DJ; Robertson, SJ; Rouquier, S; Streutker, CJ; Turpin, W; Zanello, G | 1 |
Johnson, AW; Lin, J; Sidman, JD | 1 |
Iakubov, AV; Khamraev, AA; Pulatova, NI | 1 |
Du, FC; Fu, Q; Gan, le L; Guo, G; Liu, KY; Sun, HW; Yue, ZY; Zhang, WJ; Zhang, Y; Zou, QM | 1 |
Gide, PS; Thombre, NA | 1 |
Beckett, EL; Essilfie, AT; Foster, PS; Gibson, PG; Hansbro, PM; Horvat, JC; Kim, RY; Mayall, JR; Pinkerton, JW; Simpson, JL; Starkey, MR | 1 |
Bolduc, DL; Elliott, TB; Fatanmi, OO; Kiang, JG; Ledney, GD; Newman, VL; Romaine, PL; Singh, VK; Wise, SY | 1 |
Antunes, A; Deghmane, AE; Fiette, L; Levy, M; Taha, MK | 1 |
Bell, RL; Goodwani, S; Rao, PS; Sari, Y | 1 |
Li, X; Shi, L; Tao, Y; Yang, S; Yuan, T; Zhang, F | 1 |
Feng, J; Shi, W; Zhang, S; Zhang, Y | 1 |
Deka, M; Kalita, S; Kandimalla, R; Kataki, AC; Kotoky, J; Sharma, KK | 1 |
Angolkar, T; Buttar, HS; Kaur, G; Yadav, R | 1 |
Doehn, JM; Fischetti, VA; Gutbier, B; Hippenstiel, S; Loeffler, JM; Müller, H; Rosseau, S; Schmeck, B; Schütte, H; Suttorp, N; Tschernig, T; Witzenrath, M; Zahlten, J; Zemlin, M | 1 |
Benetiere, J; Berard, F; Bienvenu, J; Hennino, A; Nicolas, JF; Rodet, K; Rozieres, A; Vocanson, M | 1 |
Butler, RN; Campbell, MA; Huynh, HQ; Kritas, S; Lee, SS; Tran, CD | 1 |
Callaghan, DO; Coudane, J; de Tayrac, R; Garric, X; Lavigne, JP; Letouzey, V | 1 |
Kintner, J; Phillips Campbell, R; Schoborg, RV; Whittimore, J | 1 |
García-Calvo, G; García-Olmos, M; Nieto, E; Parra, A; Ponte, C; Soriano, F | 1 |
Bugnon, D; Caillon, J; Grandière-Perez, L; Jacqueline, C; Le Mabecque, V; Patey, O; Potel, G | 1 |
Kolesnikow, T; Lee, A; Leung, V; O'Rourke, JL; van Zanten, SJ | 1 |
Aguilar, L; Carcas, A; Cenjor, C; Garcia-Olmos, M; Gimenez, MJ; Parra, A; Ponte, C; Soriano, F | 1 |
Ishizone, S; Katsuyama, T; Maruta, F; Miyagawa, S; Ota, H; Sugiyama, A | 1 |
Hofhuis, FM; van der Meer, C; Willers, JM | 1 |
Banevicius, MA; Du, X; Lee, SY; Maglio, D; Nicolau, DP; Sun, HK | 1 |
Decostere, A; Ducatelle, R; Haesebrouck, F; Hellemans, A | 1 |
Cartier, LL; Cheung, BW; Ji, P; Sawchuk, RJ | 1 |
Catherall, EJ; Irwin, R; Mizen, L | 1 |
Cenjor, C; del Prado, G; Fernández-Roblas, R; Gracia, M; Huelves, L; Martínez-Marín, C; Ponte, C; Rodríguez-Cerrato, V; Soriano, F | 1 |
Entenza, JM; Giddey, M; Moreillon, P; Vouillamoz, J | 1 |
Balasubramaniam, J; Mishra, B; Rajinikanth, PS | 1 |
Beubler, E; Gerstgrasser, N; Gorkiewicz, G; Hinterleitner, TA; Högenauer, C; Krause, R; Krejs, GJ; Langner, C; Lippe, IT; Schicho, R | 1 |
Harris, EJ; Krishna, U; Peek, RM; Perez-Perez, GI; Romero-Gallo, J; Washington, MK | 1 |
Beale, AS; Bryant, JE; Gisby, J; Toseland, CD | 1 |
Beale, AS; Upshon, PA | 1 |
Azoulay-Dupuis, E; Bauchet, J; Bédos, JP; Bourget, P; Moine, P; Pocidalo, JJ; Vallée, E | 1 |
Canafax, DM; Erdmann, GR; Giebink, GS; Le, CT; Lovdahl, MJ; Russlie, H | 1 |
Anastassiadou, H; Dassiou, M; Samonis, G | 1 |
Andremont, A; Carbon, C; Massias, L; Montravers, P | 1 |
Barry, B; Gehanno, P; Muffat-Joly, M; Pocidalo, JJ | 1 |
Cimochowski, CR; Faiella, JA; Girard, AE | 1 |
Karita, M; Nakazawa, T; Okita, K; Sugiyama, T; Tsuda, M | 1 |
Aho, P; Höök-Nikanne, J; Kärkkäinen, P; Kosunen, TU; Salaspuro, M | 1 |
Nieto, E; Parra, A; Ponte, C; Soriano, F | 2 |
Alder, JD; Ewing, PJ; Mitten, MJ; Oleksijew, A; Tanaka, SK | 1 |
Azoulay-Dupuis, E; Bédos, JP; Carbon, C; Darras-Joly, C; Moine, P; Rieux, V; Sauve, C | 1 |
Ikeda, F; Karita, M; Matsumoto, S; Matsumoto, Y; Tawara, S; Washizuka, Y; Yokota, Y | 2 |
Bayer, A; Bolger, AF; Dajani, AS; Ferrieri, P; Gage, TW; Gewitz, MH; Hutto, C; Levison, ME; Newburger, JW; Nouri, S; Pallasch, TJ; Peter, G; Shulman, ST; Taubert, KA; Wilson, W; Zuccaro, G | 1 |
Aguilar, L; Cenjor, C; García-Calvo, G; Giménez, MJ; Nieto, E; Parra, A; Ponte, C; Soriano, F | 1 |
Goddard, AF | 1 |
Conroy, MC; Duprez, A; Jehl, F; Le Faou, A; Lozniewski, A; Muhale, F; Renault, C; Weber, M | 1 |
Buisson, M; Chavanet, P; Coulon, A; Duong, M; Lequeu, C; Martin, L; Piroth, L; Portier, H | 1 |
Azami, H; Barrett, D; Matsumoto, S; Matsumoto, Y; Morinaga, C; Takasugi, H; Yoshida, Y | 1 |
Albut, R; Figueira, M; Pelton, SI; Stalker, D | 1 |
Baglie, S; Filho, TR; Groppo, FC | 1 |
Charles, PE; Chavanet, P; Desbiolles, N; Lequeu, C; Martin, L; Mateo-Ponce, V; Piroth, L; Portier, H | 1 |
Aguilar, L; Alkorta, M; Giménez, MJ; Pérez-Trallero, E; Vicente, D | 1 |
Kaisho, T; Kanamaru, T; Miyagawa, KI; Nakano, Y; Nakao, M; Tada, M; Toyoda, Y | 1 |
Melhus, A | 1 |
Coenen, TM; Ratajczak, HV | 1 |
Aguilar, L; Casal, J; Fenoll, A; Giménez, MJ; Jado, I; Prieto, J; Yuste, J | 1 |
Domon, H; Inoue, H; Ishii, C; Koga, T; Okazaki, Y; Utsui, Y | 1 |
Fukai, K; Kashiwagi, Y; Okubo, N; Shibata, M; Zenyoji, H | 1 |
Bergan, T | 1 |
Cleeland, R; Grunberg, E; Kramer, MJ | 1 |
Smith, GM; Sutherland, R | 1 |
Abbott, KH; Smith, GM; Sutherland, R | 1 |
Azoulay-Dupuis, E; Bedos, JP; Hardy, DJ; Pocidalo, JJ; Swanson, RN; Vallée, E | 1 |
Abbott, KH; Beale, AS; Smith, GM; Sutherland, R; Wilkinson, MJ | 1 |
Colombo, VE; Gächter, A; Thiel, G; Widmer, AF; Zimmerli, W | 1 |
Hashimoto, I; Maezawa, I; Matsushita, T; Nakamura, T; Ohshima, S; Okuno, S; Sawada, Y; Yamaguchi, T | 1 |
Canafax, DM; Erdmann, GR; Giebink, GS; Juhn, SK; Le, CT; Nonomura, N | 1 |
Galera-Davidson, H; Leal Bermudez, J; Lopez-Garrido, J; Martinez Navarro, AE; Ortega Medina, I; Rodriguez Fernandez, A | 1 |
Dijkmans, BA; Mattie, H; Vaishnav, J | 1 |
Harrison, SM; Morrison, RE; Tramont, EC | 1 |
Cooper, JE | 1 |
2 review(s) available for amoxicillin and Disease Models, Animal
Article | Year |
---|---|
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium | 2019 |
Studies on aminopenicillin developments. Proceedings of a symposium. Concluding remarks.
Topics: Administration, Oral; Amoxicillin; Ampicillin; Animals; Bacteria; Bacterial Infections; Disease Models, Animal; Humans; In Vitro Techniques; Kinetics | 1979 |
91 other study(ies) available for amoxicillin and Disease Models, Animal
Article | Year |
---|---|
Synthesis and anti-Helicobacter pylori activity of FR182024, a new cephem derivative.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clarithromycin; Disease Models, Animal; Helicobacter pylori; Lactams; Mice; Molecular Structure | 1999 |
Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics.
Topics: Amoxicillin; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae | 2007 |
Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.
Topics: Adjuvants, Immunologic; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Aortic Valve; Aza Compounds; Dexamethasone; Disease Models, Animal; Echocardiography; Endocarditis, Bacterial; Fluoroquinolones; Humans; Methicillin; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Rapid eradication of Listeria monocytogenes by moxifloxacin in a murine model of central nervous system listeriosis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Brain; Brain Diseases; Central Nervous System Bacterial Infections; Disease Models, Animal; Fluoroquinolones; Listeria monocytogenes; Listeriosis; Mice; Moxifloxacin; Quinolines; Time Factors; Treatment Outcome | 2008 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Evaluation of the collagen-binding properties and virulence of killed Streptococcus mutans in a silkworm model.
Topics: Adhesins, Bacterial; Amoxicillin; Animals; Bombyx; Cardiovascular Diseases; Carrier Proteins; Collagen; Dental Caries; Disease Models, Animal; Humans; Muramidase; Saliva; Streptococcal Infections; Streptococcus mutans; Virulence | 2022 |
Impact of Oral Probiotics in Amelioration of Immunological and Inflammatory Responses on Experimentally Induced Acute Diverticulitis.
Topics: Amoxicillin; Animals; Colitis; Disease Models, Animal; Diverticulitis; Inflammation; Lipopolysaccharides; Probiotics; Rats | 2023 |
Protective effects of amoxicillin and probiotics on colon disorders in an experimental model of acute diverticulitis disease.
Topics: Amoxicillin; Animals; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Diverticulitis; Lipopolysaccharides; Models, Theoretical; Probiotics; Rats; Tumor Necrosis Factor-alpha | 2022 |
Exposure to Amoxicillin in Early Life Is Associated With Changes in Gut Microbiota and Reduction in Blood Pressure: Findings From a Study on Rat Dams and Offspring.
Topics: Age Factors; Amoxicillin; Animals; Anti-Bacterial Agents; Blood Pressure; Disease Models, Animal; Female; Gastrointestinal Microbiome; Gestational Age; Hypertension; Lactation; Male; Maternal Exposure; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Inbred Dahl; Succinic Acid; Veillonellaceae | 2020 |
Bioactive antibacterial bilayer PCL/gelatin nanofibrous scaffold promotes full-thickness wound healing.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cell Proliferation; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Gelatin; Male; Nanofibers; Neovascularization, Physiologic; Polyesters; Rats, Sprague-Dawley; Skin; Tensile Strength; Wound Healing; Wounds and Injuries; Zinc Oxide | 2020 |
Goat and cow milk differ in altering microbiota composition and fermentation products in rats with gut dysbiosis induced by amoxicillin.
Topics: Amoxicillin; Animals; Cattle; Disease Models, Animal; Dysbiosis; Fermentation; Gastrointestinal Microbiome; Goats; Male; Milk; Rats; Rats, Sprague-Dawley | 2021 |
Early Life Antibiotics Influence In Vivo and In Vitro Mouse Intestinal Epithelium Maturation and Functioning.
Topics: Amoxicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Disease Models, Animal; Enterocytes; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Intestines; Metronidazole; Mice; Oligonucleotide Array Sequence Analysis; Permeability; Postnatal Care; Vacuoles; Vancomycin | 2021 |
Antioxidative Nanoparticles Significantly Enhance Therapeutic Efficacy of an Antibacterial Therapy against Listeria monocytogenes Infection.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antioxidants; Cyclic N-Oxides; Disease Models, Animal; Drug Synergism; Humans; Listeria monocytogenes; Listeriosis; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Oxidation-Reduction; Oxidative Stress; Polymers; Reactive Oxygen Species; Sepsis; Treatment Outcome | 2018 |
Amelioration of Escherichia coli-induced endometritis with ascorbic acid in non-pregnant mouse models.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Ascorbic Acid; Disease Models, Animal; Endometritis; Endometrium; Escherichia coli; Escherichia coli Infections; Female; Hematologic Tests; Humans; Mice; Mice, Inbred Strains; Uterus | 2018 |
Nod2 influences microbial resilience and susceptibility to colitis following antibiotic exposure.
Topics: Amoxicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Colitis; Disease Models, Animal; Disease Susceptibility; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Gene-Environment Interaction; Humans; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Nod2 Signaling Adaptor Protein; Risk | 2019 |
Bioluminescent imaging of pneumococcal otitis media in chinchillas.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacterial Load; Chinchilla; Disease Models, Animal; Ear, Middle; Luminescent Measurements; Otitis Media; Pneumococcal Infections | 2013 |
[Effect of schemes second line quadruple therapy on interactions of some protective factors in gastric mucosal tissue in experimental ulcer].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Disease Models, Animal; Drug Therapy, Combination; Gastric Mucosa; Male; Nitric Oxide; Omeprazole; Organometallic Compounds; Rats; Stomach Ulcer; Tetracycline | 2013 |
Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pronase; Stomach | 2014 |
Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
Topics: Adhesiveness; Administration, Oral; Alginates; Amoxicillin; Animals; Anti-Bacterial Agents; Biological Availability; Caesalpinia; Calorimetry, Differential Scanning; Chitosan; Crystallography, X-Ray; Delayed-Action Preparations; Disease Models, Animal; Dosage Forms; Drug Carriers; Drug Compounding; Female; Galactose; Gastric Mucosa; Glucuronic Acid; Helicobacter Infections; Helicobacter pylori; Hexuronic Acids; Kinetics; Male; Mannans; Models, Chemical; Particle Size; Powder Diffraction; Rats, Wistar; Solubility; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical | 2016 |
Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Asthma; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Dexamethasone; Disease Models, Animal; Female; Glucocorticoids; Haemophilus Infections; Haemophilus influenzae; Mice; Mice, Inbred BALB C | 2015 |
Combined immunomodulator and antimicrobial therapy eliminates polymicrobial sepsis and modulates cytokine production in combined injured mice.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Bacterial Infections; Chemokines; Cord Factors; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Female; Gamma Rays; Growth Substances; Immunologic Factors; Levofloxacin; Lipid A; Mice; Radiation Injuries, Experimental; Sepsis; Skin; Wound Infection | 2015 |
Impact of corticosteroids on experimental meningococcal sepsis in mice.
Topics: Adrenal Cortex Hormones; Amoxicillin; Animals; Biomarkers; Cytokines; Dexamethasone; Disease Models, Animal; Drug Interactions; Female; Gene Expression Regulation; Genotype; Humans; Meningococcal Infections; Mice; Mice, Inbred BALB C; Mice, Transgenic; Neisseria meningitidis; Sepsis; Transferrin | 2015 |
Amoxicillin and amoxicillin/clavulanate reduce ethanol intake and increase GLT-1 expression as well as AKT phosphorylation in mesocorticolimbic regions.
Topics: Alcohol Deterrents; Alcohol Drinking; Amoxicillin; Animals; Anti-Bacterial Agents; Ceftriaxone; Central Nervous System Depressants; Choice Behavior; Dietary Sucrose; Disease Models, Animal; Ethanol; Excitatory Amino Acid Transporter 2; Male; Nucleus Accumbens; Phosphorylation; Prefrontal Cortex; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Water | 2015 |
Bacterial extract OM-85 BV protects mice against experimental chronic rhinosinusitis.
Topics: Adjuvants, Immunologic; Administration, Oral; Amoxicillin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cell Extracts; Chronic Disease; Disease Models, Animal; Female; Inflammation Mediators; Inhalation Exposure; Interferon-gamma; Mice, Inbred BALB C; Rhinitis; RNA, Messenger; Sinusitis; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Tumor Necrosis Factor-alpha | 2015 |
Persister mechanisms in Borrelia burgdorferi: implications for improved intervention.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacterial Proteins; Borrelia burgdorferi; Disease Models, Animal; DNA Repair; Dogs; Doxycycline; Endopeptidase Clp; Haplorhini; Humans; Lyme Disease; Mice; RNA, Bacterial; RNA, Ribosomal; Sequence Analysis, RNA; Transcriptome; Treatment Failure; Up-Regulation | 2015 |
Amoxicillin functionalized gold nanoparticles reverts MRSA resistance.
Topics: Adiantum; Amoxicillin; Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Disease Models, Animal; Drug Carriers; Gold; Gram-Negative Bacteria; Gram-Positive Bacteria; Green Chemistry Technology; Kidney; Liver; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Microwaves; Plant Components, Aerial; Spectrophotometry, Atomic; Staphylococcal Infections | 2016 |
Antibacterial and Antiinflammatory Properties of Bovine Colostrum.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacteria; Carrageenan; Cattle; Colostrum; Diclofenac; Disease Models, Animal; Disk Diffusion Antimicrobial Tests; Edema; Inflammation; Rats, Wistar | 2016 |
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.
Topics: Amoxicillin; Animals; Disease Models, Animal; Female; Mice; Mice, Inbred C57BL; Muramidase; Pneumonia, Pneumococcal | 2009 |
CD8+ T cells mediate skin allergy to amoxicillin in a mouse model.
Topics: Amoxicillin; Animals; CD8-Positive T-Lymphocytes; Disease Models, Animal; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Delayed; Mice; Mice, Inbred BALB C; Skin; Skin Diseases; Skin Tests | 2010 |
Novel combination therapy for the eradication of Helicobacter pylori infection in a mouse model.
Topics: Acetylcysteine; Amoxicillin; Animals; Anti-Bacterial Agents; Cattle; Colostrum; Disease Models, Animal; Drug Therapy, Combination; Female; Helicobacter Infections; Mice; Mice, Inbred C57BL; Treatment Outcome; Zinc | 2010 |
Is degradable antibiotic coating for synthetic meshes provide protection against experimental animal infection after fascia repair?
Topics: Absorbable Implants; Amoxicillin; Animals; Anti-Bacterial Agents; Coated Materials, Biocompatible; Disease Models, Animal; Drug Implants; Escherichia coli; Hernia, Abdominal; Rats; Surgical Mesh | 2012 |
Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB/c mice.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacterial Shedding; Cell Line; Chlamydia Infections; Chlamydia muridarum; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred BALB C; Microbial Viability; Microscopy, Electron, Transmission; RNA, Bacterial; Uterus; Vagina | 2012 |
Effect of dexamethasone and pentoxifylline in combination with amoxicillin in the treatment of penicillin-insensitive pneumococcal pneumonia in guinea pigs.
Topics: Amoxicillin; Animals; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Guinea Pigs; Microbial Sensitivity Tests; Penicillin Resistance; Pentoxifylline; Pneumonia, Pneumococcal; Probability; Random Allocation; Reference Values; Statistics, Nonparametric; Survival Rate; Treatment Outcome | 2002 |
[In vivo activity of amoxicillin in a non-toxigenic Corynebacterium diphtheriae rabbit endocarditis experimental model].
Topics: Amoxicillin; Animals; Corynebacterium diphtheriae; Disease Models, Animal; Endocarditis, Bacterial; Rabbits; Reference Values | 2002 |
Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Omeprazole; Organometallic Compounds; Penicillins; Pyloric Antrum | 2003 |
Does acetaminophen interfere in the antibiotic treatment of acute otitis media caused by a penicillin-resistant pneumococcus strain? A gerbil model.
Topics: Acetaminophen; Acute Disease; Amoxicillin; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Clavulanic Acid; Disease Models, Animal; Drug Interactions; Erythromycin; Female; Gerbillinae; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 2003 |
Eradication of Helicobacter pylori decreases mucosal alterations linked to gastric carcinogenesis in Mongolian gerbils.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Carcinogenicity Tests; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Epithelial Cells; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Hypromellose Derivatives; Male; Methylcellulose; Omeprazole; Ophthalmic Solutions; Stomach Neoplasms | 2005 |
Induction of acquired cellular resistance in mice with viable and macrophage-processed Listeria monocytogenes.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Female; Immunity, Cellular; Listeria monocytogenes; Listeriosis; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Minocycline; Time Factors | 1982 |
Efficacy of pulsatile amoxicillin and clarithromycin dosing alone and in combination in a murine pneumococcal pneumonia model.
Topics: Administration, Oral; Amoxicillin; Animals; Bacterial Proteins; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Membrane Proteins; Methyltransferases; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Pulse Therapy, Drug; Streptococcus pneumoniae | 2005 |
Evaluation of antibiotic treatment against "Candidatus Helicobacter suis" in a mouse model.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; DNA, Bacterial; Feces; Helicobacter heilmannii; Helicobacter Infections; Immunohistochemistry; Mice; Mice, Inbred BALB C; Polymerase Chain Reaction; Stomach | 2005 |
Microdialysis studies of the distribution of antibiotics into chinchilla middle ear fluid.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Chinchilla; Disease Models, Animal; Dose-Response Relationship, Drug; Ear, Middle; Half-Life; Microbial Sensitivity Tests; Microdialysis; Otitis Media; Streptococcus pneumoniae | 2005 |
Comparative efficacy of amoxycillin + clavulanic acid (augmentin), flucloxacillin and vancomycin against S. aureus endocarditis in the rat.
Topics: Amoxicillin; Animals; Clavulanic Acid; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Floxacillin; Male; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |
Impact of ibuprofen therapy in the outcome of experimental pneumococcal acute otitis media treated with amoxicillin or erythromycin.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Child; Disease Models, Animal; Drug Therapy, Combination; Erythromycin; Female; Gerbillinae; Humans; Ibuprofen; Otitis Media; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2006 |
Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Blood Proteins; Daptomycin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Microbial Sensitivity Tests; Microbial Viability; Protein Binding; Rats; Rats, Wistar; Teicoplanin; Vancomycin | 2006 |
Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Calcium Carbonate; Chemistry, Pharmaceutical; Citrates; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Compounding; Feasibility Studies; Gastric Acid; Gels; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Kinetics; Male; Polysaccharides, Bacterial; Sodium Citrate; Solubility; Stomach; Time Factors; Viscosity | 2007 |
Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Toxins; Cecum; Colon; Colonoscopy; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Klebsiella Infections; Klebsiella oxytoca; Male; Middle Aged; Multivariate Analysis; Rats; Rats, Sprague-Dawley | 2006 |
Effect of Helicobacter pylori eradication on gastric carcinogenesis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Amoxicillin; Animals; Animals, Outbred Strains; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Interferon-gamma; Lansoprazole; Male; Specific Pathogen-Free Organisms; Stomach Neoplasms; Time Factors | 2008 |
Staphylococcal osteomyelitis--a comparison of co-amoxiclav with clindamycin and flucloxacillin in an experimental rat model.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Clavulanic Acids; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Floxacillin; Male; Osteomyelitis; Rats; Staphylococcal Infections; Staphylococcus aureus; Tibia | 1994 |
Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Clavulanic Acids; Disease Models, Animal; Doxycycline; Drug Therapy, Combination; Female; Fertility; Genital Diseases, Female; Mice; Microbial Sensitivity Tests; Minocycline; Progesterone; Time Factors; Vagina | 1994 |
In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Topics: Amoxicillin; Animals; Ceftriaxone; Disease Models, Animal; Female; Injections, Subcutaneous; Lung; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1994 |
Comparison of two otitis media models for the study of middle ear antimicrobial pharmacokinetics.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Chinchilla; Diffusion; Disease Models, Animal; Ear, Middle; Half-Life; Otitis Media; Rabbits; Streptococcus pneumoniae; Sulfamethoxazole; Trimethoprim | 1994 |
Antibiotics affecting gastrointestinal colonization of mice by yeasts.
Topics: Amikacin; Amoxicillin; Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Cefotaxime; Digestive System; Disease Models, Animal; Feces; Gastrointestinal Diseases; Male; Mice; Mice, Inbred ICR; Pefloxacin | 1994 |
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 1994 |
Effect of increased dosages of amoxicillin in treatment of experimental middle ear otitis due to penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gerbillinae; Otitis Media; Penicillin Resistance; Pneumococcal Infections | 1993 |
The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Endocarditis, Bacterial; Erythromycin; Female; Gerbillinae; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Otitis Media; Pneumococcal Infections; Pneumonia; Rats; Roxithromycin; Streptococcal Infections; Streptococcus pyogenes | 1993 |
Evaluation of a new bismuth-free triple therapy in nude mice and humans.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Colony Count, Microbial; Contraindications; Disease Models, Animal; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Mice; Mice, Inbred BALB C; Mice, Nude; Penicillins; Peptic Ulcer; Recurrence; Severity of Illness Index; Treatment Outcome | 1995 |
The Helicobacter felis mouse model in assessing anti-Helicobacter therapies and gastric mucosal prostaglandin E2 levels.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Catechols; Dinoprostone; Disease Models, Animal; Drug Therapy, Combination; Erythromycin; Gastric Mucosa; Helicobacter Infections; Male; Mice; Mice, Inbred BALB C; Organometallic Compounds; Pentanones; Tetracycline; Tinidazole | 1996 |
Correlation of in-vitro activity and pharmacokinetic parameters with in-vivo effect of amoxycillin, co-amoxiclav and cefotaxime in a murine model of pneumococcal pneumonia.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Cefotaxime; Cephalosporins; Clavulanic Acids; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1996 |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Ferrets; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Time Factors | 1996 |
Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem.
Topics: Amoxicillin; Animals; Cefotaxime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Female; Guinea Pigs; Lung; Meropenem; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins | 1996 |
Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.
Topics: Amoxicillin; Animals; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Disease Models, Animal; Female; Lung; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1996 |
Induction of ulceration and severe gastritis in Mongolian gerbil by Helicobacter pylori infection.
Topics: Amoxicillin; Animals; Disease Models, Animal; Gastric Mucosa; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Penicillins; Pyloric Antrum; Specific Pathogen-Free Organisms; Stomach Ulcer | 1997 |
Prevention of bacterial endocarditis: recommendations by the American Heart Association.
Topics: Algorithms; American Dental Association; American Heart Association; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Clindamycin; Clinical Protocols; Consensus Development Conferences as Topic; Dental Care; Dental Care for Chronically Ill; Disease Models, Animal; Disease Susceptibility; Endocarditis, Bacterial; Erythromycin; Follow-Up Studies; Humans; MEDLINE; Mitral Valve Prolapse; Outcome Assessment, Health Care; Penicillins; Retrospective Studies; Risk Factors; Societies, Medical; Treatment Failure; United States | 1997 |
Appearance of a metronidazole-resistant Helicobacter pylori strain in an infected-ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strains.
Topics: Amoxicillin; Animals; Antitrichomonal Agents; Disease Models, Animal; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Male; Metronidazole; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillins | 1997 |
In vivo efficacies of amoxicillin and cefuroxime against penicillin-resistant Streptococcus pneumoniae in a gerbil model of acute otitis media.
Topics: Acute Disease; Amoxicillin; Animals; Cefuroxime; Disease Models, Animal; Drug Therapy, Combination; Gerbillinae; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 1998 |
Getting to the route of Helicobacter pylori treatment.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Delivery Systems; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Patient Compliance | 1998 |
Gastric penetration of amoxicillin in a human Helicobacter pylori-infected xenograft model.
Topics: Amoxicillin; Animals; Disease Models, Animal; Fetal Tissue Transplantation; Gastric Juice; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Infusions, Parenteral; Mice; Mice, Nude; Penicillins; Transplantation, Heterologous | 1999 |
Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics.
Topics: Amoxicillin; Animals; Disease Models, Animal; Humans; Male; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Rabbits; Streptococcus pneumoniae | 1999 |
Studies on anti-Helicobacter pylori agents. Part 1: Benzyloxyisoquinoline derivatives.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Helicobacter Infections; Helicobacter pylori; Isoquinolines; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillins; Structure-Activity Relationship | 1999 |
Efficacy of linezolid in experimental otitis media.
Topics: Acetamides; Amoxicillin; Animals; Anti-Bacterial Agents; Chinchilla; Disease Models, Animal; Drug Resistance, Microbial; Drug Resistance, Multiple; Haemophilus Infections; Haemophilus influenzae; Humans; Linezolid; Otitis Media; Oxazoles; Oxazolidinones; Pneumococcal Infections; Streptococcus pneumoniae | 2000 |
Tissue pharmacokinetics of amoxicillin. An experimental design in rats.
Topics: Amoxicillin; Animals; Disease Models, Animal; Male; Microbial Sensitivity Tests; Penicillins; Rats; Rats, Wistar; Staphylococcus aureus; Tissue Distribution | 2000 |
HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Humans; Ketolides; Macrolides; Male; Penicillins; Pneumonia, Pneumococcal; Rabbits; Streptococcus pneumoniae; Treatment Outcome | 2001 |
Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin.
Topics: Amoxicillin; Animals; Area Under Curve; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Forecasting; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Predictive Value of Tests; Sepsis; Streptococcus pneumoniae | 2001 |
In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Drug Resistance, Microbial; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Humans; Indoles; Male; Microbial Sensitivity Tests; Penicillins; Stomach Diseases; Tryptophan-tRNA Ligase | 2001 |
Effects of amoxicillin on the expression of cytokines during experimental acute otitis media caused by non-typeable Haemophilus influenzae.
Topics: Acute Disease; Amoxicillin; Animals; Cytokines; Disease Models, Animal; Male; Otitis; Penicillins; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2001 |
Equal allergenic potency of beta-lactam antibiotics produced by chemical or enzymatic manufacturing--mouse IgE test.
Topics: Allergens; Amoxicillin; Animals; Anti-Bacterial Agents; Cephalexin; Disease Models, Animal; Drug Hypersensitivity; Female; Humans; Immunization; Immunoglobulin E; Male; Mice; Mice, Inbred BALB C; Passive Cutaneous Anaphylaxis; Rabbits; Rats; Rats, Sprague-Dawley | 2001 |
Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model.
Topics: Amoxicillin; Animals; Antibodies, Bacterial; Antibody Specificity; beta-Lactams; Cefotaxime; Disease Models, Animal; Humans; Immune Sera; Mice; Mice, Inbred BALB C; Pneumococcal Infections; Sepsis; Streptococcus pneumoniae; Treatment Outcome | 2002 |
Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Diterpenes; Drug Synergism; Drug Therapy, Combination; Fatty Alcohols; Helicobacter Infections; Helicobacter pylori; Male; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Stomach | 2002 |
[On the activity of amoxicillin against experimental Treponema infection (author's transl)].
Topics: Amoxicillin; Ampicillin; Animals; Disease Models, Animal; Male; Penicillin Resistance; Rabbits; Syphilis; Treponema pallidum | 1977 |
Activity of oral amoxicillin, ampicillin, and oxytetracycline against infection with chlamydia trachomatis in mice.
Topics: Administration, Oral; Amoxicillin; Ampicillin; Animals; Chlamydia Infections; Chlamydia trachomatis; Disease Models, Animal; Mice; Oxytetracycline; Pneumonia | 1979 |
Activity of amoxycillin-clavulanic acid against Legionella pneumophila in vitro and in an experimental respiratory infection model.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Clavulanic Acids; Disease Models, Animal; Drug Therapy, Combination; Humans; Legionella pneumophila; Legionnaires' Disease; Microbial Sensitivity Tests; Neutropenia; Rats | 1992 |
Bactericidal effects of co-amoxiclav (amoxycillin clavulanic acid) against a Legionella pneumophila pneumonia in the immunocompromised weanling rat.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Clavulanic Acids; Disease Models, Animal; Drug Combinations; Immunocompromised Host; Injections, Subcutaneous; Legionella pneumophila; Legionnaires' Disease; Male; Pneumonia; Rats; Rats, Inbred Strains | 1992 |
Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Erythromycin; Female; Fluoroquinolones; Lung; Mice; Mice, Inbred C57BL; Ofloxacin; Pneumonia, Pneumococcal; Quinolones; Sepsis; Streptococcus pneumoniae | 1991 |
Bactericidal effects of amoxycillin/clavulanic acid against a Legionella pneumophila pneumonia in the weanling rat.
Topics: Age Factors; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Clavulanic Acids; Disease Models, Animal; Drug Therapy, Combination; Legionnaires' Disease; Lung; Male; Microscopy, Electron; Rats; Species Specificity | 1991 |
Salmonella infection in total hip replacement: tests to predict the outcome of antimicrobial therapy.
Topics: Adult; Amoxicillin; Animals; Arthritis, Infectious; Bacterial Adhesion; Ciprofloxacin; Diffusion Chambers, Culture; Disease Models, Animal; Guinea Pigs; Hip Prosthesis; Humans; Immunosuppression Therapy; Male; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Salmonella; Salmonella Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
A new model of bacterial peritonitis in mice for evaluation of antibiotics. Effects of aspoxicillin and piperacillin.
Topics: Amoxicillin; Ampicillin Resistance; Animals; Ascitic Fluid; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Male; Mice; Peritonitis; Piperacillin | 1989 |
Experimental animal models for studying antimicrobial pharmacokinetics in otitis media.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Chinchilla; Disease Models, Animal; Ear, Middle; Eustachian Tube; Injections, Intramuscular; Otitis Media; Pressure; Rabbits; Radiography; Sulfamethoxazole; Trimethoprim; Tympanic Membrane | 1989 |
Dexamethasone-prepared Escherichia coli-induced disseminated intravascular coagulation. Animal model.
Topics: Amoxicillin; Animals; Dexamethasone; Disease Models, Animal; Disseminated Intravascular Coagulation; Escherichia coli Infections; Female; Immunosuppression Therapy; Kidney Glomerulus; Lymphoid Tissue; Mucins; Rats; Rats, Inbred Strains; Thymus Gland | 1987 |
Efficacy of amoxycillin and benzylpenicillin combined with clavulanic acid against Bacteroides fragilis in vitro and in experimentally infected mice.
Topics: Amoxicillin; Animals; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; Penicillin G | 1985 |
Oral amoxycillin, an alternative treatment for neurosyphilis.
Topics: Administration, Oral; Amoxicillin; Animals; Disease Models, Animal; Female; Humans; Male; Neurosyphilis; Probenecid; Rabbits; Treponema pallidum | 1985 |
Safety and efficacy of clavulanate-potentiated amoxycillin in pigeons (Columba livia).
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacteria; Bird Diseases; Clavulanic Acid; Clavulanic Acids; Columbidae; Disease Models, Animal; Drug Synergism; Feces; Foot Diseases; Safety; Staphylococcal Infections | 1985 |